Poster: CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway
Year: 2021
Type: article
Authors: Lodovico Terzi di Bergamo, Gabriela Forestieri, Jui Wan Loh, Amartya Singh, Valeria Spina, Antonella Zucchetto, Adalgisa Condoluci, Martin Faderl, Ricardo Koch, Alessio Bruscaggin, Katia Pini, Wei Wu, Deborah Piffaretti, Tamara Bittolo, Erika Tissino, Lorenzo De Paoli, Clara Deambrogi, Anna Maria Frustaci, Francesco Autore, Michele Merli, Lydia Scarfò, Silvia Rasi, Jakob Passweg, Riccardo Moia, Claudio Martines, Paolo Ghia, Franco Cavalli, Emanuele Zucca, Bernhard Gerber, Silke Gillessen, Georg Stüssi, Marco Montillo, Francesco Passamonti, Michael Gregor, Luca Laurenti, Alessandra Tedeschi, Gianluca Gaidano, Dimitar Efremov, Valter Gattei, Hossein Khiabanian, Davide Rossi
Institutions: Institute of Oncology Research, Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Centro di Riferimento Oncologico, Istituto Oncologico della Svizzera Italiana, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Agostino Gemelli University Polyclinic, University of Insubria, Ospedale di Circolo e Fondazione Macchi, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, IRCCS San Raffaele Roma, University Hospital of Basel, International Centre for Genetic Engineering and Biotechnology, Università della Svizzera italiana, Luzerner Kantonsspital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4200571498